Coya Therapeutics: Linking Inflammation and Oxidative Stress to Parkinson's Disease Progression

Coya Therapeutics has announced a new research study linking inflammation and oxidative stress to the progression of Parkinson's disease. The study, led by Drs. Aaron Thome and Stanley H. Appel, explores the role of immune dysfunction in PD pathogenesis. The results show upregulation of pro-inflammatory cytokines and chemokine receptors in PD monocytes compared to controls, and highlight the potential of Coya's multitargeted immunomodulatory approach in treating severe neurodegenerative diseases.